Waiting list

26 March 11:00-16:30Rotundan, Universum

Time for the 3rd Open up for Innovation – the event that highlights good examples of how Academia and Industry can collaborate to create a win-win for the parties and a greater outcome for society.

This quote sums up the subject well: "Harnessing motivations to facilitate collaboration to enriching overall expertise and access unique resources such as technology, knowledge, and capabilities, involves careful navigation of barriers and optimal use of enablers. The resulting University-Industry-Collaboration allows firms and universities to tap into complementary skills of each other and thus potentially help with saving cost and enhancing research outcomes" (Hemmertetal.,2014;605).

We expect around 70 researchers and 30 industry professionals to gather and connect to learn more about the potential in mutual collaborations and be inspired by those who already work in partnerships.

WELCOME to learn more about this on the 26th of March in Rotundan, Umeå University

Registration deadline: 18th of March (registrants after this will be put on a waiting list). 

PDF: Info & Schedule 

Some voices from the previous events:

Mikael Elofsson, professor in Chemistry: “One reason to promote collaboration is that it makes academia better and more competitive.”
Jessica Martinsson, CEO Sweden BIO: “This event is a good example of collaboration. I hope other universities can do similar events.”
Emil Byström, CEO SpinChem: “Start to collaborate without funding, work on shorter projects, build trust, and then sign agreements. As a company, we often speak in terms of weeks, whereas academia thinks over years.”
Teresa Frisan, Professor in Cell and Molecular Biology: "Innovation is created when you open up and interact with others, if you are always inside the same box, you don’t learn anything outside the box." 
Magnus Wolf-Watz, Professor in Biophysical chemistry: "As a researcher, it’s exciting to take fundamentally new steps and to be closer to utilizing our research. But to be able to collaborate, you need to have a big enough research group or partner with other research groups.”
David Lough, Director Academic Partnerships, Chiesi: “Thank you for giving me the opportunity to participate in Open Up for Innovation – really good event!”

Waiting list

Schedule

11:00

Intro

The moderator, Andreas Lindberg, greets you at Open Up for Innovation. 

Read more
11:10

Vision 2035 and the Regional Life Science Strategy

Umeå University's Vision 2035 
(Mikael Elofsson)
The Regional Life Science Strategy 

(Göran Larsson)

Read more
11:40

Fireside chat: Umeå Life Science companies on stage

What's cooking in the industry? Presentation of local companies and their representatives. 

Read more
12:00

Lunch

Mingle and make new contacts! 

Read more
13:00

Three Perspectives on Collaboration

13.00-13.30: "Advancing life sciences research with unique research infrastructure access - and how Caffe Bueno was made with the NMR unit"
(Linda Sandblad, Site Director, SciLifeLab Umeå).
13.30-14.00: 
"Data-driven strategies for precision probiotic development"
(Chinmay Dwibedi, Umeå University, and Stefan Roos, Director Preclinic & Discovery, BioGaia AB).
14.00-14.30:
 "Co‑Creating the Future of Enzyme Technology: Insights from UiT and ArcticZymes Technologies"
(Peik Haugen, UiT The Arctic University of Norway, and Dr. Olav Lanes, ArcticZymes Technologies)

Read more
14:30

Fika & Mingle

15:00

Proteomics in Partnership

"Unlocking the Proteome Together: Olink’s Journey and Partnerships Powering Scientific Discovery"
(Ida Lautenbach, PhD, senior strategic advisor, Olink® — Part of ThermoFisher Scientific, Owner of Umeå-based Agrisera).

Read more
15:30

Keynote speaker: Rita Balice-Gordon - Cross‑Sector Biomedical Insights

"Working Across the Biomedical Ecosystem: Learnings from a Career in Academia, Pharma and BioTech". 
(Rita Balice-Gordon, Adj Professor of Neuroscience, CEO of Muna Therapeutics).

Read more
16:00

Panel discussion and audience Q&A

In the panel: 
Mikael Elofsson, Professor of Chemistry, Umeå University,
Anna Ramnemark, Head of Unit, Clinical Research Centre, Region Västerbotten,
Ida Lautenbach, PhD, Olink,
Rita Balice-Gordon, Adj Professor of Neuroscience, Muna Therapeutics

Read more

Speakers 

Chinmay Dwibedi, PhD, Group leader, MIMS and UCMR, and DDLS Fellow, SciLifeLab. 

Göran Larsson, Director of Research and Education, Region Västerbotten

Ida Lautenbach, PhD, senior strategic advisor, Olink.

Linda Sandblad, Site Director, SciLifeLab Umeå. 

Mikael Elofsson, Professor at Dept. of Chemistry at Umeå University. 

Peik Haugen, Head of Department, Professor of Molecular Biosystems and Bioinformatics, Norstruct, UiT The Arctic University of Norway

Dr. Olav Lanes, VP R&D and Applications, Arctic Zymes Technologies

Rita Balice-Gordon, PhD, CEO, Muna Therapeutics
Brings 30 years of experience in neuroscience research, drug discovery and development from senior leadership roles in biopharma and a distinguished academic research career.

Anna Ramnemark, Head of Unit, Clinical Research Centre, Region Västerbotten. 

Stefan Roos, Director of Preclinic & Discovery, BioGaia AB.

Organizations contributing to the program 

ArcticZymes Technologies: Inspired by our Arctic environment, we transform over 30 years of experience, insights and passion for enzymes, into high-quality products, empowering your discovery in molecular research, diagnostics, or therapeutics.

BioGaia AB: BioGaia is a world leader in probiotic research and development. Since 1990, our clinically proven probiotics have supported the health and well-being of both children and adults

Muna Therapeutics: Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s and Parkinson’s.

Olink - Part of Thermo Fisher Scientific: Olink’s mission is to accelerate proteomics together with the scientific community, to understand real-time biology and gain actionable insights into human health and disease.

Region Västerbotten

SciLifeLab: A state-of-the-art national infrastructure for life science. SciLifeLab provides researchers in fields such as biomedicine, ecology, and evolution with access to advanced technologies and expertise.

UiT - The Arctic University of Norway: UiT is the northernmost university in the world. UiT's key research focuses on the polar environment, climate research, indigenous people, peace and conflict transformation, telemedicine, medical biology, space physics, fishery science, marine biosprospecting, linguistics and computational chemistry.

Umeå University 

Non-stage participating companies/organizations 

Agrisera: Provides off-the-shelf antibodies for plant and algal research, with prompt delivery worldwide, and reactivity to thousands of species.

Boreal Orchards: Boreal Orchards is an EcoTech company developing innovative solutions for climate adaptation, urban greenery, and ecosystem restoration.

Diamyd Medical: Develops precision medicine therapies for the prevention and treatment of autoimmune diabetes. A biologics manufacturing facility is being set up in Umeå, with the primary purpose of manufacturing recombinant GAD65.

FOI: The Swedish Defence Research Agency is one of Europe’s leading research institutes in defence and security. FOI is a government agency under the Ministry of Defence, and most of its activities are assignment-based. 

Lipum: Lipum AB is a biopharmaceutical company specializing in the discovery and development of new treatments for chronic inflammatory diseases. The drug candidate SOL-116 is in clinical phase with compelling preclinical data for rheumatoid arthritis (RA).

Medicvent: The mission is to develop, manufacture, and promote a comprehensive range of products for the evacuation of air pollution, primarily in hospital care settings.

Nordic BioConsult: Specializes in delivering expert consulting, efficient project management, and innovative method development to accelerate biotechnology research and its real-world applications.

Pro Test Diagnostics: Pro Test Diagnostics AB develops a blood doping test to reveal athletes who, by means of blood transfusions, have increased their performance ability.

QureTech Bio: A biotechnology company focused on the development of novel therapeutics targeting infectious diseases and cancer.

Sartorius (Umeå): Develops advanced data analytics and DoE software that drives digital innovation and supports more efficient development and manufacturing in the pharmaceutical industry.

SpinChem: SpinChem provides technology solutions that reshape the way chemical process work is performed.

SwedenBio: Sweden’s national industry organization for the life science sector.

SweTree Technologies: A research and technology development company within the area of forest biotechnology. The goal is to develop and introduce innovative technologies and products to the global forestry market.

Testa Center: An initiative between the Swedish government and Cytiva. The main objective is to bridge the gap from discovery to industrialization. 

UmanDiagnostics: Committed to delivering fast and accurate diagnosis of neurological diseases. The company develops and markets valuable tools for early detection of disease.

Moderators

Andreas Lindberg

Business Coach at Umeå Biotech Incubator with 20 years of experience in the Medtech and pharmaceuticals industry. 

Read more

Important Info

Purpose of meeting: This meeting is about joining forces between researchers in Academia and the Life Science Industry to ignite more collaboration for innovative research and translation of this research into impact for better health.

Who can join? This event is directed to researchers within Life Sciences working at Umeå University, Region Västerbotten and SLU, and companies within Life Science connected to Umeå and Norrland. If you are not one of these categories and still believe you can contribute during this day – please reach out to Umeå Biotech Incubator and we can let you know if you can join.

Participation fee: This event is sponsored by Umeå Biotech Incubator (UBI) with support from the European Union. There is no actual fee for participating. For delegates from the industry, state-aid/de-minimis will be accounted for corresponding to 3 000 SEK per person.

NOTE: If you have registered and don’t show up – we have a “no-show” fee of 200 SEK.

State aid & de-minimis: Umeå Biotech Incubator is obliged to account for activities they arrange, and support they provide, directed to specific companies or a group of companies where the receiving companies do not pay market price for the participation. The value of this support is accounted for as state-aid.
Small amounts of State aid (‘de minimis’ aid) are exempted from State aid control, as they are deemed to have no impact on competition and trade in the internal market of the European Union (EU). De minimis aid indeed refers to small amounts of State aid to undertakings (companies) that do not have to be notified to the European Commission by the EU Member States. The maximum amount is € 300,000 for each undertaking over 3 years. De minimis can be granted also to large companies that are not entitled to larger sums of state-aid under Article 22.
Read more on state-aid and de-minimis here:

GDPR: Photographs will be taken during the event. By signing up for the event you also agree to be seen on pictures from this event posted on LinkedIn, Facebook, and Umeå Biotech Incubators website.

Registration deadline:
18th of March, 1:00 PM. 

CONTACT: For questions regarding this event, please contact Andreas Lindberg, andreas.lindberg@ubi.se, 076-669 73 19.

Waiting list

Organized by